Cargando…

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis

Tumours lacking argininosuccinate synthetase-1 (ASS1) are auxotrophic for arginine and sensitive to amino-acid deprivation. Here, we investigated the role of ASS1 as a biomarker of response to the arginine-lowering agent, pegylated arginine deiminase (ADI-PEG20), in lymphoid malignancies. Although A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delage, B, Luong, P, Maharaj, L, O'Riain, C, Syed, N, Crook, T, Hatzimichael, E, Papoudou-Bai, A, Mitchell, T J, Whittaker, S J, Cerio, R, Gribben, J, Lemoine, N, Bomalaski, J, Li, C-F, Joel, S, Fitzgibbon, J, Chen, L-T, Szlosarek, P W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406582/ https://www.ncbi.nlm.nih.gov/pubmed/22764101 http://dx.doi.org/10.1038/cddis.2012.83

Ejemplares similares

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
por: Syed, N, et al.
Publicado: (2013)

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase
por: Kelly, M P, et al.
Publicado: (2012)

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
por: Beddowes, Emma, et al.
Publicado: (2017)

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
por: Feun, L G, et al.
Publicado: (2012)

RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells
por: Wu, Fe-Lin Lin, et al.
Publicado: (2011)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin
por: Savaraj, Niramol, et al.
Publicado: (2015)

Role of 3'-Deoxy-3'-[(18)F] Fluorothymidine Positron Emission Tomography-Computed Tomography as a Predictive Biomarker in Argininosuccinate Synthetase 1-Deficient Thoracic Cancers Treated With Pegargiminase
por: Szyszko, Teresa A., et al.
Publicado: (2022)

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms
por: Szlosarek, Peter W., et al.
Publicado: (2020)

Epithelial argininosuccinate synthetase is dispensable for intestinal regeneration and tumorigenesis
por: van der Meer, Jonathan H. M., et al.
Publicado: (2021)

Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
por: Liu, Jiangbo, et al.
Publicado: (2014)

Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy
por: McAlpine, Jennifer A, et al.
Publicado: (2014)

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma
por: Savaraj, Niramol, et al.
Publicado: (2007)

A transgenic approach to study argininosuccinate synthetase gene expression
por: Shiue, Shih-Chang, et al.
Publicado: (2014)

Cytosolic Delivery of Argininosuccinate Synthetase Using a Cell-Permeant Miniature Protein
por: Knox, Susan L., et al.
Publicado: (2021)

Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer
por: SHAN, YAN-SHEN, et al.
Publicado: (2015)

Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance
por: Kim, Youngji, et al.
Publicado: (2016)

Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
por: Zheng, Liang, et al.
Publicado: (2013)

Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model
por: Shiue, Shih-Chang, et al.
Publicado: (2015)

Citrullinemia type I in Chinese children: Identification of two novel argininosuccinate synthetase gene mutations
por: Xiong, Mei, et al.
Publicado: (2022)

Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1
por: Locke, Matthew, et al.
Publicado: (2016)

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines
por: Shan, Yan-Shen, et al.
Publicado: (2015)

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma
por: Thongkum, Angkana, et al.
Publicado: (2017)

High-throughput enrichment of temperature-sensitive argininosuccinate synthetase for two-stage citrulline production in E. coli
por: Schramm, Thorben, et al.
Publicado: (2020)

Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism
por: Zhang, Yiming, et al.
Publicado: (2022)

Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma
por: Liu, Qingqing, et al.
Publicado: (2017)

Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression
por: Kim, Stephanie S., et al.
Publicado: (2020)

Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines
por: Roeksomtawin, Somphon, et al.
Publicado: (2018)

Refeeding syndrome in a young woman with argininosuccinate lyase deficiency()
por: Stuy, M., et al.
Publicado: (2015)

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
por: Chang, Kwang-Yu, et al.
Publicado: (2021)

Landscape requirements of a primate population in a human-dominated environment
por: Hoffman, Tali S, et al.
Publicado: (2012)

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
por: Burrows, Natalie, et al.
Publicado: (2016)

Expanding the phenotype in argininosuccinic aciduria: need for new therapies
por: Baruteau, Julien, et al.
Publicado: (2017)

Phylogenetic Evidence That Two Distinct Trichuris Genotypes Infect both Humans and Non-Human Primates
por: Ravasi, Damiana F., et al.
Publicado: (2012)

Behavioral Causes, Ecological Consequences, and Management Challenges Associated with Wildlife Foraging in Human-Modified Landscapes
por: Fehlmann, Gaelle, et al.
Publicado: (2020)

Low percentage of clinically relevant pistachio nut and mango co-sensitisation in cashew nut sensitised children
por: van der Valk, J. P. M., et al.
Publicado: (2017)

Novel mutations underlying argininosuccinic aciduria in Saudi Arabia
por: Imtiaz, Faiqa, et al.
Publicado: (2010)

Beauty or beast? Farmers’ dualistic views and the influence of aesthetic appreciation on tolerance towards black-backed jackal and caracal
por: Drouilly, Marine, et al.
Publicado: (2021)

Small-livestock farmers’ perceived effectiveness of predation control methods and the correlates of reported illegal poison use in the South African Karoo
por: Drouilly, Marine, et al.
Publicado: (2023)

Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer
por: Baruteau, Julien, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ac7sfqka8v1l123ggpbdlnl1kq